UniQure's Gene Therapy Shows Promise, CDC Warns of Bacterial Surge, FDA Reviews ENHERTU Cancer Combo, New HIV Prevention Injection, and more...
Update: 2025-09-25
Description
(0:10 ): UniQure's Gene Therapy AMT-130 Slows Huntington's Disease by 75%, Boosts Stock 190%
(2:00 ): CDC Warns of 70% Surge in 'Nightmare Bacteria' Infections, Urges Global Action Against Antibiotic Resistance
(4:11 ): FDA Grants Priority Review to ENHERTU Combo for HER2+ Breast Cancer, Promising New Standard of Care
(6:02 ): Revolutionary $40 HIV Prevention Injection to Reach 120 Countries by 2027
(7:55 ): Gore's Climate TRACE Unveils Global Pollution Tracking with Satellite and AI Technology
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Tech Space 2.0
(2:00 ): CDC Warns of 70% Surge in 'Nightmare Bacteria' Infections, Urges Global Action Against Antibiotic Resistance
(4:11 ): FDA Grants Priority Review to ENHERTU Combo for HER2+ Breast Cancer, Promising New Standard of Care
(6:02 ): Revolutionary $40 HIV Prevention Injection to Reach 120 Countries by 2027
(7:55 ): Gore's Climate TRACE Unveils Global Pollution Tracking with Satellite and AI Technology
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Tech Space 2.0
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
